FDMT: 4D Molecular Therapeutics, Inc. Stock

by  •  • Comments Off on FDMT: 4D Molecular Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 134.74
Enterprise Value ($M) -14.60
Book Value ($M) 510.61
Book Value / Share 11.03
Price / Book 0.26
NCAV ($M) 385.15
NCAV / Share 8.32
Price / NCAV 0.35

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.27

Liquidity (mrq)
Quick Ratio 14.92
Current Ratio 14.92

Balance Sheet (mrq) ($M)
Current Assets 434.93
Assets 560.38
Liabilities 49.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.04
Operating Income -187.84
Net Income -160.87

Cash Flow Statement (mra) ($M)
Cash From Operations -134.59
Cash from Investing -302.44
Cash from Financing 337.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G/A BlackRock, Inc. 7.80 -27.18
02-14 13G/A Ra Capital Management, L.p. 9.90 -10.46
02-14 13G/A Deep Track Capital, LP 1.32 -85.11
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 6.40 -32.90
02-14 13G/A Janus Henderson Group Plc 4.90 -28.21
02-14 13G/A Biotechnology Value Fund L P 9.99 -34.52
02-10 13G/A Goldman Sachs Group Inc 9.60 23.15
11-14 13G/A Viking Global Investors Lp 0.00 -100.00
11-12 13G/A Vanguard Group Inc 5.32 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 42,357 317,157 13.36
2025-04-16 75,884 385,009 19.71
2025-04-15 134,207 798,737 16.80
2025-04-14 70,830 733,437 9.66

(click for more detail)

Similar Companies
ERAS – Erasca, Inc. EWTX – Edgewise Therapeutics, Inc.
EXEL – Exelixis, Inc. FGEN – FibroGen, Inc.
GBIO – Generation Bio Co.


Financial data and stock pages provided by
Fintel.io